uftoral has been researched along with Bladder Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, T; Baba, S; Hirayama, T; Irie, A; Iwabuchi, K; Iwamura, M; Kudoh, O; Matsumoto, K; Uchida, T | 1 |
| Fujimoto, K; Hirao, Y; Okajima, E; Ozono, S; Tsujimoto, S | 1 |
| Akaza, H; Hattori, K; Ishikawa, S; Kawai, K; Kikuchi, K; Kobayashi, T; Koiso, K; Kondo, F; Manabe, F; Matsuki, K; Miyanaga, N; Noguchi, R; Shimazui, T; Suzuki, R; Takeshima, H; Tsuchiya, A; Uchida, K | 1 |
| Goto, R; Ikeuchi, T; Kai, Y; Ota, M; Yoshikawa, H | 1 |
| Akaza, H; Tsukamoto, S | 1 |
| Hatano, T; Hokama, S; Ogawa, Y; Touyama, H | 1 |
1 review(s) available for uftoral and Bladder Cancer
| Article | Year |
|---|---|
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
1 trial(s) available for uftoral and Bladder Cancer
| Article | Year |
|---|---|
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Diethylstilbestrol; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1998 |
4 other study(ies) available for uftoral and Bladder Cancer
| Article | Year |
|---|---|
[Superficial bladder cancer with lung metastasis without local invasion: a case report].
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Pneumonectomy; Tegafur; Thoracoscopy; Uracil; Urinary Bladder Neoplasms | 2007 |
5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Rats; Rats, Inbred F344; RNA, Neoplasm; Tegafur; Uracil; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |
[A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Administration Schedule; Drug Combinations; Humans; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 1998 |
[Primary signet ring cell carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Drug Combinations; Humans; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 2001 |